SCHEDULE OF WARRANT ACTIVITY (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of Warrants, Outstanding | 13,018 | 1,032 |
| Weighted Average Exercise Price, Outstanding | $ 0.01 | $ 0.15 |
| Number of Warrants, Issued | 32,433,940 | 13 |
| Weighted Average Exercise Price, Issued | $ 0.01 | $ 0.01 |
| Number of Warrants, Expired | (9,486) | |
| Weighted Average Exercise Price, Expired | $ 0.01 | |
| Number of Warrants, Exercised | (1,375,435) | (1,899) |
| Weighted Average Exercise Price, Exercised | $ 0.01 | $ 0.01 |
| Number of Warrants, Outstanding | 31,062,037 | 13,018 |
| Weighted Average Exercise Price, Outstanding | $ 0.01 | $ 0.01 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options exercised in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|